Medical Weight Loss for Beverly Hills Patients

Medical weight loss treats excess weight as a medical condition with measurable drivers, such as insulin resistance, hormonal changes, sleep, and medications. Instead of a commercial diet plan, it starts with labs and a physician evaluation, then builds a program around your results, with prescription medication when it is appropriate and regular follow-up to track progress.

Both mimic incretin hormones released by the gut after eating. They reduce appetite and cravings, slow stomach emptying so fullness lasts longer, and improve blood sugar control. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both the GLP-1 and GIP receptors.

In the SURMOUNT-5 head-to-head trial, adults taking tirzepatide lost an average of 20.2 percent of body weight over 72 weeks, compared with 13.7 percent on semaglutide. Individual results vary. Compare them in our Semaglutide vs. Tirzepatide Guide.

FDA-approved weight loss medications are generally indicated for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition, such as high blood pressure, high cholesterol, prediabetes, or sleep apnea. GLP-1 medications are not used in people with a personal or family history of medullary thyroid carcinoma or MEN 2, during pregnancy, or in certain other situations reviewed during your consultation.

• A one-on-one consultation with Dr. Sean Kelishadi, MD FACS, not a questionnaire.
• Lab-first care, including fasting insulin, metabolic markers, and hormones.
• Pharmacist review of every medication and interaction by Sherry Kelishadi, Pharm.D.
• A focus on preserving lean muscle and planning for long-term maintenance.
• Coordinated care with hormone optimization when low testosterone or menopause are contributing factors.

Cost depends on the medication, dose, and length of your program. SSK Longevity is a direct-pay practice and does not bill insurance. Pricing is reviewed with you during your consultation, before you commit to a program.